Phase III clinical trial - Pédiatrie Neuroblastomes

HR-NBL2
Pédiatrie Neuroblastomes
Ouvert depuis le: 09.20.2021
Site: Paris
Public cible
Enfant
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Description de l'essai

This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.